BIOXCEL THERAPEUTICS INC. - COMMON STOCK
0.5848
04-October-24 14:59:45
15 minutes delayed
Stocks
+0.0347
+6.31%
Today's range
0.5500 - 0.5915
ISIN
N/A
Source
NASDAQ
-
BioXcel Therapeutics Reports First Quarter 2023 Financial Results and Recent Operational Highlights
08 May 2023 06:00:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Present at the BofA Securities 2023 Health Care Conference
02 May 2023 06:00:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Report First Quarter 2023 Financial Results on May 8, 2023
24 Apr 2023 06:00:00 By Nasdaq GlobeNewswire
-
14 Mar 2023 15:15:08 By Nasdaq GlobeNewswire
-
09 Mar 2023 06:00:01 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023
23 Feb 2023 06:00:02 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Ring Nasdaq Stock Market Closing Bell Today
21 Feb 2023 06:00:00 By Nasdaq GlobeNewswire
-
08 Feb 2023 06:00:00 By Nasdaq GlobeNewswire
-
11 Jan 2023 06:00:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference
22 Dec 2022 06:00:00 By Nasdaq GlobeNewswire
-
19 Dec 2022 06:00:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Present at Bank of America 2022 Biotech SMID Cap Conference
01 Dec 2022 06:00:01 By Nasdaq GlobeNewswire
-
30 Nov 2022 06:00:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Present at Two Upcoming Investor Conferences
14 Nov 2022 06:00:02 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics Reports Third Quarter 2022 Financial Results and Recent Operational Highlights
10 Nov 2022 06:00:04 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Report Third Quarter 2022 Financial Results on November 10, 2022
27 Oct 2022 06:00:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Host IGALMI™ Commercial Day on October 18, 2022
05 Oct 2022 06:00:00 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Participate at the H.C. Wainwright 24th Annual Global Investment Conference
07 Sep 2022 06:00:01 By Nasdaq GlobeNewswire
-
BioXcel Therapeutics Reports Second Quarter 2022 Financial Results and Recent Operational Highlights
09 Aug 2022 06:00:01 By Nasdaq GlobeNewswire